Randal J. Kirk

This profile gathers the share dealings of Randal J. Kirk across 4 companies, led by Precigen, Inc., Precipio, Inc. and Alaunos Therapeutics, Inc. In total, 49 filings cover trades dated from 31 December 2015 to 30 March 2026.

On the open market, the record shows 9 purchases worth €38.0M and 15 sales worth €25.2M. The totals do not cover 5 filings with an undisclosed amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 10 share grants and 8 option exercises. So far in 2026, the count stands at no purchases and 11 sales.

A typical purchase (the median) is worth €1.0M. On 3 out of 9 purchases, another insider of the same company was buying within the same 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.

The record was last updated on 31 March 2026 with an open-market sale (€3.2M) in Precigen, Inc. The last purchase on record was published on 13 August 2024, which is 796 days ago. The median gap between a trade and its publication by SEC (Form 4) is 3 days. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.